Astellas Pharma Reports Higher H1 Profit And Sales; Ups Sales Guidance

Astellas Pharma Inc. (ALPMY) Monday reported profit before tax of 120.48 billion yen for the first six months, higher than 89.085 billion yen in the same period a year ago.

Net profit increased to 96.434 billion yen or 52.87 yen per basic share from 71.609 billion yen or 38.65 yen per basic share last year.

Excluding one-time items, core profit rose to 119.973 billion yen or 65.78 yen per basic share from 98.756 billion yen or 53.30 yen per basic share a year ago.

Revenue for the first six months period grew to 762.185 billion from 651.666 billion yen in the previous year.

Looking forward, the company has raised its full-year 2022 sales outlook to 1,529 billion yen from the initial outlook of 1,443 billion yen. In 2021, the company had recorded revenue of 1,296.163 billion yen.

Full-year core profit is expected to be 223 billion yen or 122.05 yen per basic share. This compares with 190.584 billion yen or 103.03 yen per basic share reported last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tyson Foods, Inc. (TSN) reported that its first quarter adjusted operating income declined 68% year-over-year. Adjusted operating margin was 3.4%, for the quarter. Both lower revenue and higher COGS in Beef and Pork drove the decrease in adjusted operating margin. The company said market dynamics... Baltimore, Maryland-based Fresh Ideation Food Group LLC is recalling certain sandwiches and other products sold under various brands, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for ready-to-eat or RTE stuffed chicken product citing that it may not be fully cooked due to underprocessing.
Follow RTT